E-LIB Suche - Ergebnisse für: Herrera, Alex F

1

Outcomes of Large B-Cell Lymphoma (LBCL) Patients with Seco..:

Hashmi, Hamza ; Epperla, Narendranath ; Ahn, Kwang...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S42 , 2024

Link: https://doi.org/10.1016/..

2

Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory..:

Driessen, Julia ; de Wit, Fer ; Herrera, Alex F....
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

3

Advancing Inclusive Research (AIR) Site Alliance: Facilitat..:

Vidal, Gregory A. ; Chalela, Patricia ; Curry, Andrea N....
Contemporary Clinical Trials. 137 (2024) - p. 107416 , 2024

Link: https://doi.org/10.1016/..

4

Chimeric antigen receptor T-cell infusion for large B-cell ..:

Wang, Trent P. ; Ahn, Kwang W. ; Shadman, Mazyar...
Leukemia. , 2024

Link: https://doi.org/10.1038/..

5

Real-World Multicenter Study of PD-1 Blockade in HIV-Associ..:

Lurain, Kathryn ; Zarif, Talal El ; Ramaswami, Ramya...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

6

Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refracto..:

Mei, Matthew ; Tsai, Ni-Chun ; Palmer, Joycelynne...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

7

Comparison of whole‐genome and immunoglobulin‐based circula..:

Merryman, Reid W. ; Rhoades, Justin ; Xiong, Kan...
HemaSphere. 8 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

8

CD19-Directed CART Therapy for T Cell/Histiocyte Rich Large..:

Fein, Dr. Joshua A ; Pophali, Priyanka A. ; Ahn, Kwang...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S356 , 2024

Link: https://doi.org/10.1016/..

9

Impact of Complete Response (CR) on Long-Term Survival Amon..:

Ghobadi, Armin ; Anagnostou, Theodora ; Azzi, Jacques...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S191-S192 , 2024

Link: https://doi.org/10.1016/..

10

Five-year follow-up of KEYNOTE-087: pembrolizumab monothera..:

Armand, Philippe ; Zinzani, Pier Luigi ; Lee, Hun Ju...
Blood. 142 (2023) 10 - p. 878-886 , 2023

Link: https://doi.org/10.1182/..

11

P1068: UPDATED RESULTS FROM AN OPEN-LABEL PHASE 1/2 STUDY O..:

Timmerman, John ; Lavie, David ; Johnson, Nathalie...
HemaSphere. 7 (2023) S3 - p. e5990067 , 2023

Link: https://doi.org/10.1097/..

12

S220: REAL-WORLD OUTCOMES OF BREXUCABTAGENE AUTOLEUCEL (BRE..:

Ahmed, Nausheen ; Kambhampati, Swetha ; Hamadani, Mehdi...
HemaSphere. 7 (2023) S3 - p. e43327c1 , 2023

Link: https://doi.org/10.1097/..

13

Cost‐effectiveness of polatuzumab vedotin in combination wi..:

Kambhampati, Swetha ; Shumilov, Evgenii ; Saumoy, Monica...
British Journal of Haematology. 202 (2023) 4 - p. 771-775 , 2023

Link: https://doi.org/10.1111/..

14

Results from a phase I trial of pembrolizumab plus vorinost..:

Godfrey, James ; Mei, Matthew ; Chen, Lu...
Haematologica. 109 (2023) 2 - p. 533-542 , 2023

Link: https://doi.org/10.3324/..

15

Low T-cell proportion in the tumor microenvironment is asso..:

Song, Joo Y. ; Nwangwu, Mary ; He, Ting-Fang...
Haematologica. 108 (2023) 8 - p. 2167-2177 , 2023

Link: https://doi.org/10.3324/..